CRISPR/Cas9 gene editing in the West Nile Virus vector, Culex quinquefasciatus Say.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31714905.
- Also identified by DOI 10.1371/journal.pone.0224857 and PMC identifier 6850532.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Culex quinquefasciatus Say is an opportunistic blood feeder with a wide geographic distribution which is also a major vector for a range of diseases of both animals and humans. CRISPR/Cas technologies have been applied to a wide variety of organisms for both applied and basic research purposes. CRISPR/Cas methods open new possibilities for genetic research in non-model organisms of public health importance. In this work we have adapted microinjection techniques commonly used in other mosquito species to Culex quinquefasciatus, and have shown these to be effective at generating homozygous knock-out mutations of a target gene in one generation. This is the first description of the kmo gene and mutant phenotype in this species.
Medical subject headings
- CRISPR-Associated Protein 9
- CRISPR-Cas Systems
- Culex
- Gene Editing
- Mosquito Vectors
- West Nile virus